There may be upsides to being less mature at this stage of society’s AI shift—relentless optimism could detract from mitigating potential risks.

It’s easy to forget that generative AI launched into the economy—and the public imagination—less than two years ago. How could it be otherwise?

Patient safety should be the No. 1 consideration for healthcare organizations working, planning or hoping to adopt AI. Then again, nine other concerns are similarly crucial to the success of the industry-wide endeavor.

Here’s a factoid you may not have seen coming. By 2030, the six countries of the Gulf Cooperation Council annually purchase more than $23 billion worth of products and services related to generative AI.

No time like the present to canvass experts for their opinions on which tools are tops. 

The suggestion comes from a strategic communications professional who specializes in thinking creatively about how to unlock opportunities—including those that are, at present, hard to see.

Querying 55 thought leaders behind closed doors, the Stanford Institute for Human-Centered AI has found only 12% believe healthcare AI should always have a human in the loop.

When it comes to adopting healthcare AI, large, well-off hospitals are likely to frequently homer while smaller, struggling institutions go down looking. (Baseball analogy in honor of tonight’s Midsummer Classic.)